Influenza News and Research

Latest Influenza News and Research

U.S. not prepared for future spread of animal-borne or zoonotic diseases, analysis reveals

U.S. not prepared for future spread of animal-borne or zoonotic diseases, analysis reveals

NIH initiates a clinical trial evaluating an investigational antiviral for treatment of COVID-19

NIH initiates a clinical trial evaluating an investigational antiviral for treatment of COVID-19

Study finds RSV responsible for most infant hospitalizations in the European Union

Study finds RSV responsible for most infant hospitalizations in the European Union

Influenza A virus suppresses SARS-CoV-2 replication during co-infection

Influenza A virus suppresses SARS-CoV-2 replication during co-infection

Fear and anxiety during the COVID-19 pandemic associated with new alcohol use disorder diagnoses

Fear and anxiety during the COVID-19 pandemic associated with new alcohol use disorder diagnoses

Whole-genome CRISPR activation for the identification of host factors controlling cellular interactions with SARS-CoV-2

Whole-genome CRISPR activation for the identification of host factors controlling cellular interactions with SARS-CoV-2

New compound limits the replication of influenza viruses

New compound limits the replication of influenza viruses

Study demonstrates antiviral effects of vinegar against SARS-CoV-2

Study demonstrates antiviral effects of vinegar against SARS-CoV-2

Protein activity found to be more dysregulated in the blood of patients with alcohol-associated hepatitis

Protein activity found to be more dysregulated in the blood of patients with alcohol-associated hepatitis

A novel nomenclature system for pathogens like SARS-CoV-2

A novel nomenclature system for pathogens like SARS-CoV-2

COVID-19 vaccination increases saliva antibody levels after asymptomatic infection

COVID-19 vaccination increases saliva antibody levels after asymptomatic infection

Cellular and humoral responses and the safety of recombinant and inactivated SARS-CoV-2 vaccines in chronic kidney disease patients

Cellular and humoral responses and the safety of recombinant and inactivated SARS-CoV-2 vaccines in chronic kidney disease patients

Do individuals with long COVID ever recover fully?

Do individuals with long COVID ever recover fully?

Study characterizes mutations in neuraminidase of human-like H5N1 influenza viruses

Study characterizes mutations in neuraminidase of human-like H5N1 influenza viruses

A secret weapon in preventing the next pandemic: Fruit bats

A secret weapon in preventing the next pandemic: Fruit bats

Multi-country study examines clinical and community antibiotic use during the pandemic

Multi-country study examines clinical and community antibiotic use during the pandemic

9 out of every 10 people hospitalized with the flu have at least one underlying medical condition

9 out of every 10 people hospitalized with the flu have at least one underlying medical condition

New research may explain why some patients suffer from long-COVID

New research may explain why some patients suffer from long-COVID

AAHI awarded a $9.9 million project to develop prototype intranasal bivalent influenza RNA vaccine candidate

AAHI awarded a $9.9 million project to develop prototype intranasal bivalent influenza RNA vaccine candidate

Demographic factors influencing COVID vaccine acceptance rates among healthcare workers worldwide

Demographic factors influencing COVID vaccine acceptance rates among healthcare workers worldwide

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.